Step 2: Differential Diagnosis of Non-Response
Before changing the protocol, work through the four causes of non-response — failed engraftment, wrong diagnosis, lifestyle sabotage, or biological resistance — each calling for a different response.
Before modifying the FMT protocol, systematically assess the four main categories of non-response causation. Each has different management implications.
Category A: Engraftment Failure
The most common technical cause. Donor microbiota has not established persistent colonization in the recipient gut.
- Diagnostic indicators: no shift in stool microbiota composition at week 4 (if microbiota testing available); persistent recipient-type microbiota profile; early symptom improvement followed by relapse.
- Potential causes: antibiotic use (most common); inadequate induction dose; high recipient microbial resilience (prior engraftment-resistant patients); incompatible donor-recipient pair.
- Management: review antibiotic exposure; consider donor change (Phase 0 compatibility data reviewed); consider intensified induction protocol.
Category B: Wrong Primary Diagnosis
FMT cannot treat conditions that are primarily immune-mediated, structural, or non-microbial. Non-response may signal a diagnostic revision is required.
- IBS non-response: screen for undiagnosed IBD (calprotectin, colonoscopy), celiac disease, microscopic colitis, SIBO.
- UC non-response: rule out CMV colitis superinfection (occurs in immunosuppressed or steroid-treated UC). Rule out C. difficile co-infection.
- Metabolic non-response: assess medication effects (corticosteroids, atypical antipsychotics, antiretrovirals affecting metabolic profile).
Category C: Exposome Sabotage
Active lifestyle or environmental factors negating engraftment. Often underestimated and underreported.
- Review Food and Symptom Diary for: antibiotic exposure (including OTCs with antimicrobial properties); high-sugar ultra-processed diet; severe sleep disruption; extreme stress events.
- Non-disclosed OTC use (NSAIDs, antifungals, laxatives) is a common hidden variable. Proactive review required.
- Management: intensify exposome support before protocol modification. Partial exposome optimization often produces clinically meaningful improvement in apparent non-responders.
Category D: Indication-Specific Biological Resistance
Some patients have biological features that reduce FMT response independent of engraftment or diagnosis. These are not treatment failures in the conventional sense.
- UC: high pre-treatment fecal calprotectin (>1000 μg/g), active steroid dependence, and prior anti-TNF exposure are associated with lower FMT response rates.
- Crohn's: penetrating or stricturing phenotype (B2/B3) has lower response rate than inflammatory phenotype (B1).
- IBS: high psychological comorbidity burden predicts lower gut-level response. Parallel psychological intervention required.